COVID-19 drugs: Regulators join forces on real-world evidence
Article written by Gary Finnegan Medicines regulators from around the world are collaborating closely on the use of real-world evidence in assessing COVID-19 treatments and vaccines.
Article written by Gary Finnegan Medicines regulators from around the world are collaborating closely on the use of real-world evidence in assessing COVID-19 treatments and vaccines.
Interview and article by Christine Clark Knowing that your GP or pharmacist has had the vaccine can be deeply reassuring, according to Gary Finnegan, health journalist and Editor… read more.
Interview and article by Christine Clark Understanding the three Cs of vaccine hesitancy could be the key to ensuring effective uptake of covid-19 vaccines, according to Gary Finnegan,… read more.
Interview and article by Christine Clark As planning for a mass covid vaccination campaign gets started, an understanding of vaccines and the factors that drive vaccine confidence will… read more.
Article written by Gary Finnegan More than a third of medical staff suffered insomnia during the COVID-19 epidemic in China, according to a new study.
Article written by Gary Finnegan There are seven ‘forms of disease’ in people with mild COVID-19, according to scientists at the Medical University of Vienna.
Article written by Bruce Sylvester Patients with chronic kidney disease have achieved improved outcomes with dapagliflozin treatment, researchers reported on October 8, 2020 in the NEJM/New England Journal… read more.
Article written by Bruce Sylvester Researchers from a retrospective study have reported an association between vitamin D deficiency and an increase in the risk of becoming infected with… read more.
Article written by Bruce Sylvester. HPV (human papillomavirus) vaccination appears to significantly lower the risk of cervical cancer, researchers reported on Sept. 30, 2020 in the NEJM/New England… read more.
Article written by Bruce Sylvester Severely obese persons (BMI >35) who suffer a heart attack and who then undergo weight-reduction surgery appear to have a lower risk of… read more.
Article written by Bruce Sylvester Researchers report that capmatinib, a targeted therapy, appears to provide clinical benefit to patients who have advanced lung cancer with specific gene mutations.
Interview and article by Christine Clark Pharmacist Anita Hogg explains how well Medicines Optimisation Innovation Centre (MOIC) model to estimate the critical care drug requirements during the covid-19… read more.
Advertisment